Samik Pharmaceutical's Central Research Institute
Since its establishment in 1995 in Bupyeong, Incheon, the institute has been committed to enhancing its R&D capabilities through the recruitment of experts for specialized pharmaceutical development, collaborative research with academic institutions, and the incorporation of cutting-edge research equipment. Samik Pharmaceutical focuses on the development of specialized medications across various therapeutic areas, such as cardiovascular, endocrine, respiratory, and gastrointestinal systems. We also produce over-the-counter medications including motion sickness drugs, remedies for frail children, and comprehensive cold medicines. The institute conducts research in various domains, including the discovery of new drug candidates derived from natural substances, the improvement of existing drugs, and the development of first generics.
Samik Pharmaceutical's Driving Force for Future Growth
We are engaged in optimizing drug formulations by regulating solubility and release rates, and enhancing efficacy through drug repositioning technologies. These efforts aim to expand patients' therapeutic choices and improve their quality of life. Adhering to the humanistic philosophy of our founder, we invest in fostering top talents among our researchers by inviting distinguished scholars for lectures, offering opportunities for overseas training, and supporting advanced studies at graduate schools.
Samik Pharmaceutical's Ultimate Mission
Proactively adapting to market changes, we aim to lay the foundation for a century-old enterprise by developing innovative and safe pharmaceuticals that meet global regulatory standards. As the aging population increases, the institute is committed to expanding our excellent pipeline to meet the growing unmet needs, thereby ensuring everyone enjoys a healthy and happy life.
